Researchers have identified a drug candidate which appears to suppress a critical genetic alteration in dysfunctional cells.
According to researchers, an experimental drug extends lifespan in male mice and ameliorates a number of behavioral symptoms of Rett syndrome in female mice, signifying the disorder may be reversible.
A new study claims researchers have identified a new cause for some cases of autism and other intellectual disabilities.
Researchers have implicated a new gene associated with Rett syndrome in idiopathic autism.
Researchers report on a new technique which identifies genetic mutations that cause brain malformation.
Researchers discover three specific drugs affect three different kinds of neurotransmitter receptors which all appear to play roles in Fragile X.
According to a new study, statins could help treat Rett Syndrome.
New research suggests environmental exposure to bisphenol A (BPA), a chemical commonly found in plastics and resins, could suppress a gene critical to nerve cell function and the development of the central nervous system. Exposure to BPA could predispose humans to a number of neurodevelopmental and other health disorders.
in a mouse model of Rett syndrome, researchers were able to reverse abnormalities in brain activity and improve neurological function by treating animals with an FDA-approved anesthesia drug, ketamine.
Neuroscientists report that two major classes of brain cells repress neural activity in specific mathematical ways: One type subtracts from overall activation, while the other divides it.
Researchers from the CHUM Research Centre (CRCHUM) have identified a new gene that predisposes people to both autism and epilepsy....
The world's first basic research institute for childhood neurological diseases opened in Houston, Texas and is part of the Texas Children's Hospital. Some of the research the new research insitute will focus on includes childhood neurological diseases such as autism, epilepsy, Rett syndrome, cerebral palsy, ataxias and Batten disease. More details about the new institute are provided in the press release below.
